Line 82: | Line 82: | ||
<tr> | <tr> | ||
− | <td align="center"><img src="https://static.igem.org/mediawiki/2017/ | + | <td align="center"><img src="https://static.igem.org/mediawiki/2017/e/ef/T--Duke--Romel.png" style="width:243px;height:263px;"></td> |
<td align="center"><h4>Romel Menacho-Melgar</h4> | <td align="center"><h4>Romel Menacho-Melgar</h4> | ||
− | <p><br> | + | <p><br>Romel is a Biomedical Engineering PhD student. Originally from Peru, he came to the US to the University of South Carolina to earn a BS degree in Biomedical Engineering in 2009. He started his graduate studies at Duke in 2013 and joined the Lynch Lab in 2015. His project involves developing a platform for in vivo peptide lipidation for novel materials and pharmaceuticals</p> |
</td> | </td> | ||
</tr> | </tr> |
Revision as of 06:54, 9 September 2017
Our Wonderful Team of Advisors
Advisors
Michael Lynch
|
|
Adim Moreb
|
|
John Decker
|
Mentors
Johnathon Burg
|
|
Zhixia Ye
|
|
Charlie Cooper
|
|
Jennifer Hennigan
|
|
Romel Menacho-Melgar
|